Cinclus Pharma Net Asset Quality Index
Cinclus Pharma net asset quality index. Cinclus Pharma (CINPHA) has a Net Asset Quality Index of 47.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr424.54 Million minus total liabilities of Skr221.84 Million yields net assets of Skr202.70 Million. A higher index indicates a stronger, lower-leverage balance sheet. See CINPHA net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Cinclus Pharma (2022–2025)
Net asset quality index of Cinclus Pharma from 2022 to 2025. This chart shows how Cinclus Pharma's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 47.7%, representing net assets of Skr202.70 Million against total assets of Skr424.54 Million SEK. Check Cinclus Pharma tangible equity quality to evaluate the tangible quality of the company's equity base.
Cinclus Pharma Net Asset Quality Index by Year (2022–2025)
Cinclus Pharma net asset quality index by year from 2022 to 2025. The table below presents the year-by-year Net Asset Quality Index for Cinclus Pharma from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CINPHA stock market capitalisation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.6% | Skr369.39 Million | Skr546.56 Million | Skr177.16 Million | ▼ -24.8 pp |
| 2024 | 92.4% | Skr555.33 Million | Skr601.01 Million | Skr45.68 Million | ▲ +173.7 pp |
| 2023 | -81.3% | Skr-76.80 Million | Skr94.41 Million | Skr171.21 Million | ▼ -149.6 pp |
| 2022 | 68.3% | Skr126.87 Million | Skr185.77 Million | Skr58.90 Million | — |